Comparison of biomarker and chromatographic analytical approaches to pharmacokinetic study of sitagliptin

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Vera M. Kosman, Marina V. Karlina, Natalia M. Faustova, Valery G. Makarov, Marina N. Makarova
{"title":"Comparison of biomarker and chromatographic analytical approaches to pharmacokinetic study of sitagliptin","authors":"Vera M. Kosman,&nbsp;Marina V. Karlina,&nbsp;Natalia M. Faustova,&nbsp;Valery G. Makarov,&nbsp;Marina N. Makarova","doi":"10.1002/bdd.2305","DOIUrl":null,"url":null,"abstract":"<p>The pharmacokinetic profiling of active compounds is necessary for drug development and application. Approaches to a pharmacokinetic study based on biological markers are alternatives to traditional approaches based on chromatographic methods. The aim of the study was to compare two analytical approaches to pharmacokinetics investigation for an example of sitagliptin in rabbits after one dose oral administration. The method for sitagliptin quantification in rabbit plasma samples based on a correlation between its concentration and dipeptidyl peptidase IV activity was proposed, validated, and applied. The high-performance liquid chromatography (HPLC)-ultraviolet (UV) method was also validated and applied for the same sample analysis. The plasma pharmacokinetics of sitagliptin after oral administration to the rabbits in one dose was characterized after two analytical assays. The close values of the main pharmacokinetic parameters were obtained after two approaches. The nontraditional approach based on correlation of special marker activity and active substance concentration appears to be more sensitive than HPLC-UV. Thus, the sitagliptin concentrations determined by biomarker assay were higher than the lower limit of quantification (LLOQ) for a longer period (more timepoints) than after the HPLC-UV assay. This feature may influence the values of some calculated concentration-dependent (area under the curve [AUC]<sub>0-<i>t</i></sub>, etc.) and time-dependent parameters (mean residence time [MRT], <i>T</i><sub>1/2</sub>, etc.). The values of <i>T</i><sub>max</sub> obtained by the two approaches were similar and adequate for oral drug administration that confirms the correctness of biomarker selection for pharmacokinetics assessment. The obtained results on the example of sitagliptin confirms that the biomarker approach is adequate and applicable for a pharmacokinetics study. Similar approaches may be effective for individual compounds and complex mixtures when it is difficult or impossible to analyze them traditionally by chromatographic methods.</p>","PeriodicalId":8865,"journal":{"name":"Biopharmaceutics & Drug Disposition","volume":"43 1","pages":"3-10"},"PeriodicalIF":1.7000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopharmaceutics & Drug Disposition","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdd.2305","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The pharmacokinetic profiling of active compounds is necessary for drug development and application. Approaches to a pharmacokinetic study based on biological markers are alternatives to traditional approaches based on chromatographic methods. The aim of the study was to compare two analytical approaches to pharmacokinetics investigation for an example of sitagliptin in rabbits after one dose oral administration. The method for sitagliptin quantification in rabbit plasma samples based on a correlation between its concentration and dipeptidyl peptidase IV activity was proposed, validated, and applied. The high-performance liquid chromatography (HPLC)-ultraviolet (UV) method was also validated and applied for the same sample analysis. The plasma pharmacokinetics of sitagliptin after oral administration to the rabbits in one dose was characterized after two analytical assays. The close values of the main pharmacokinetic parameters were obtained after two approaches. The nontraditional approach based on correlation of special marker activity and active substance concentration appears to be more sensitive than HPLC-UV. Thus, the sitagliptin concentrations determined by biomarker assay were higher than the lower limit of quantification (LLOQ) for a longer period (more timepoints) than after the HPLC-UV assay. This feature may influence the values of some calculated concentration-dependent (area under the curve [AUC]0-t, etc.) and time-dependent parameters (mean residence time [MRT], T1/2, etc.). The values of Tmax obtained by the two approaches were similar and adequate for oral drug administration that confirms the correctness of biomarker selection for pharmacokinetics assessment. The obtained results on the example of sitagliptin confirms that the biomarker approach is adequate and applicable for a pharmacokinetics study. Similar approaches may be effective for individual compounds and complex mixtures when it is difficult or impossible to analyze them traditionally by chromatographic methods.

Abstract Image

生物标志物与色谱分析方法在西格列汀药代动力学研究中的比较
活性化合物的药代动力学分析是药物开发和应用的必要条件。基于生物标记的药代动力学研究方法是基于色谱方法的传统方法的替代方法。本研究的目的是比较西格列汀单剂量口服后在家兔体内的药代动力学研究的两种分析方法。提出了一种基于西格列汀浓度与二肽基肽酶IV活性相关性的兔血浆样品西格列汀定量方法,并对其进行了验证和应用。验证了高效液相色谱(HPLC)-紫外(UV)法,并将其应用于同一样品的分析。采用两种方法对西格列汀单剂量口服家兔的血浆药代动力学进行了研究。两种方法均获得了较为接近的主要药动学参数。基于特殊标记物活性与活性物质浓度相关性的非传统方法比高效液相色谱-紫外法更敏感。因此,与HPLC-UV法相比,生物标志物法测定的西格列汀浓度高于定量下限(LLOQ)的时间更长(时间点更多)。这一特征可能会影响一些与浓度相关的计算值(曲线下面积[AUC]0-t等)和与时间相关的参数(平均停留时间[MRT], T1/2等)。两种方法获得的Tmax值相似,足以用于口服给药,这证实了用于药代动力学评估的生物标志物选择的正确性。以西格列汀为例获得的结果证实,生物标志物方法是充分的,适用于药代动力学研究。当传统的色谱方法难以或不可能分析单个化合物和复杂混合物时,类似的方法可能对它们有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
35
审稿时长
6-12 weeks
期刊介绍: Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: - animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, - in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man - studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, - simulation and modeling in drug discovery and development - theoretical treatises - includes themed issues and reviews and exclude manuscripts on - bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation - analytical methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信